Details of the Drug
General Information of Drug (ID: DMOS68D)
Drug Name |
(4-fluorophenyl)(pyridin-4-yl)methanone
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-(4-Fluorobenzoyl)pyridine; 41538-36-7; (4-fluorophenyl)(pyridin-4-yl)methanone; Methanone, (4-fluorophenyl)-4-pyridinyl-; CHEMBL563196; 4-fluorophenyl 4-pyridyl ketone; (4-fluorophenyl)-pyridin-4-ylmethanone; AC1ODYVS; 3fu0; ACMC-20amw5; AC1Q4LVT; SCHEMBL4618020; CTK1D3778; DTXSID60427471; MolPort-001-628-204; WTRWBYGUMQEFFI-UHFFFAOYSA-N; ZINC2583439; (4-Pyridyl)(p-fluorophenyl) ketone; BDBM50294173; MFCD02683088; SBB092751; 4-[(4-fluorophenyl)carbonyl]pyridine; AKOS003603273; MCULE-1391167832; DB06917; NE40002
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 201.2 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||